Oncology API

1
Oncology APIs
DMF Status
Azacitidine USDMF 27487
Bendamustine HCl USDMF 25222
Bicalutamide USDMF 24690
Bortezomib USDMF 24944
Busulfan R0-CEP 2011-339-Rev 01, USDMF 25491
Capecitabine USDMF 24689
Decitabine USDMF 27488
Erlotinib HCl USDMF 29124
Gemcitabine HCl CEP R0-CEP 2006-222, USDMF 24136
Imatinib Mesylate USDMF 27927
Irinotecan HCl Trihydrate USDMF 23562
Letrozole R0-CEP 2013-321-Rev 00, USDMF 27489
Melphalan HCl USDMF 28930
Oxaliplatin R0-CEP 2006-201, USDMF 23563
Pemetrexed Dipotassium Nona hydrate DMF available
Pemetrexed Disodium Hemipentahydrate USDMF 25102
Temozolomide USDMF 23479
Zoledronic acid USDMF 25905
Anastrozole DMF available
Axitinib DMF available
Clofarabine DMF available
Abiraterone Acetate Tech. Pack available
Cabazitaxel Tech. Pack available
Cladribine Tech. Pack available
Cyclophosphamide Tech. Pack available
Cytarabine Tech. Pack available
Dasatinib Monohydrate Tech. Pack available
Docetaxel Tech. Pack available
Enzalutamide Tech. Pack available
Gefitinib Tech. Pack available
Lenalidomide Tech. Pack available
Paclitaxel Tech. Pack available
Regarofinib Tech. Pack available
Sorafenib Tosylate Tech. Pack available
Sunitinib Tech. Pack available
Thalidomide Tech. Pack available
Products covered by valid patents in any country
are not offered or supplied to those countries.
2
Non-Oncology APIs
DMF Status
Ambroxol HCl R1-CEP 2004-201 Rev 02
Fingolimod HCl USDMF 28162
Phenylephrine HCl CEP 2012-060
Acebrophylline DMF available
Nifedipine DMF available
Sildenafil Citrate DMF available
Dimethyl Fumarate DMF available
Pirfenidone Teck Pack available
Prucalopride Succinate Teck Pack available
Ursodeoxycholic acid (from our Italian Principal) Ursodeoxycholic acid (from our Italian Principal)
ARV List
DMF Status
Tenofovir DMF available
Emtricitabine Teck Pack available
Elvitegravir Teck Pack available
Cobicistat Teck Pack available
Under Development-Oncology APIs
Afatinib Dimaleate Bosutinib Crizotinib
Carfilzomib Ibrutinib Lapatinib Distosylate
Mecitentan Odanacatib Nintedanib
Nilotinib Pomalidomide Vemurafenib
Vismodegib
For enquiries, please contact
Shilpa Medicare Limited 10/80, Rajendra Gunj,
Raichur 584 102 (India) Tel [phone],
Fax [phone] eMail vishnu_at_vbshilpa.com,
Web www.vbshilpa.com
Products covered by valid patents in any country
are not offered or supplied to those countries.